Top compounds associated with response to PDCL3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.01
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.12 0.02
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.18 0.02
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.075 0.02
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.087 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA niclosamide CTRPv2 pan-cancer AAC 0.085 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.02
mRNA TAE684 CTRPv2 pan-cancer AAC -0.083 0.02
Download CSV